Table 2.
Variables
|
Training cohort, n = 500
|
Validation cohort, n = 62
|
||||
Model
|
PM
|
ALBI
|
MELD
|
PM
|
ALBI
|
MELD
|
AUC (95%CI) | 0.833 (0.792-0.873) | 0.651 (0.598-0.703) | 0.508 (0.436-0.548) | 0.802 (0.684-0.920) | 0.658 (0.536-0.774) | 0.631 (0.499-0.750) |
Sensitivity, % | 83.100 (118/142) | 43.700 (62/142) | 62.000 (88/142) | 95.500 (21/22) | 72.300 (13/22) | 59.100 (13/22) |
Specificity, % | 73.500 (263/358) | 80.200 (287/358) | 53.100 (190/358) | 52.500 (21/40) | 57.500 (29/40) | 72.500 (29/40) |
P value | - | < 0.0011 | < 0.0012 | - | 0.0403 | 0.0484 |
Area under receiver operating characteristic curve (AUC) values of the albumin-bilirubin (ALBI) score compared to that of the posthepatectomy liver failure model (PM) in the training cohort.
AUC values of the model for end-stage liver disease (MELD) score compared to that of the PM in the training cohort.
AUC values of the ALBI score compared to that of the PM in the validation cohort.
AUC values of the model for end-stage liver disease score compared to that of the PM in the validation cohort.
CI: Confidence interval.